Your browser doesn't support javascript.
loading
A clinical decision support system optimising adjuvant chemotherapy for colorectal cancers by integrating deep learning and pathological staging markers: a development and validation study.
Kleppe, Andreas; Skrede, Ole-Johan; De Raedt, Sepp; Hveem, Tarjei S; Askautrud, Hanne A; Jacobsen, Jørn E; Church, David N; Nesbakken, Arild; Shepherd, Neil A; Novelli, Marco; Kerr, Rachel; Liestøl, Knut; Kerr, David J; Danielsen, Håvard E.
Afiliação
  • Kleppe A; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway; Department of Informatics, University of Oslo, Oslo, Norway.
  • Skrede OJ; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway; Department of Informatics, University of Oslo, Oslo, Norway.
  • De Raedt S; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway; Department of Informatics, University of Oslo, Oslo, Norway.
  • Hveem TS; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway.
  • Askautrud HA; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway.
  • Jacobsen JE; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway; Department of Research and Development, Vestfold Hospital Trust, Tønsberg, Norway.
  • Church DN; National Institute of Health Research Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK; Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
  • Nesbakken A; Department of Gastrointestinal Surgery, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; KG Jebsen Colorectal Cancer Research Centre, Oslo, Norway.
  • Shepherd NA; Gloucestershire Cellular Pathology Laboratory, Cheltenham General Hospital, Cheltenham, UK.
  • Novelli M; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway; Research Department of Pathology, University College London, London, UK.
  • Kerr R; Department of Oncology, University of Oxford, Oxford, UK.
  • Liestøl K; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway; Department of Informatics, University of Oslo, Oslo, Norway.
  • Kerr DJ; Nuffield Division of Clinical Laboratory Sciences, University of Oxford, Oxford, UK.
  • Danielsen HE; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway; Department of Informatics, University of Oslo, Oslo, Norway; Nuffield Division of Clinical Laboratory Sciences, University of Oxford, Oxford, UK. Electronic address: hdaniels@ifi.uio.no.
Lancet Oncol ; 23(9): 1221-1232, 2022 09.
Article em En | MEDLINE | ID: mdl-35964620
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Sistemas de Apoio a Decisões Clínicas / Aprendizado Profundo Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Sistemas de Apoio a Decisões Clínicas / Aprendizado Profundo Idioma: En Ano de publicação: 2022 Tipo de documento: Article